(Q34988147)

English

Antigen-specific CD4 T cells are induced after intravesical BCG-instillation therapy in patients with bladder cancer and show similar cytokine profiles as in active tuberculosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Antigen-specific CD4 T cells are induced after intravesical BCG-instillation therapy in patients with bladder cancer and show similar cytokine profiles as in active tuberculosis (English)

1 reference

Europe PubMed Central

5 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Urban Sester

6

0 references

author name string

Julia Elsäßer

1

1 reference

Europe PubMed Central

5 August 2017

Martin W Janssen

2

1 reference

Europe PubMed Central

5 August 2017

Frank Becker

3

1 reference

Europe PubMed Central

5 August 2017

Henrik Suttmann

4

1 reference

Europe PubMed Central

5 August 2017

Kai Schmitt

5

1 reference

Europe PubMed Central

5 August 2017

Michael Stöckle

7

1 reference

Europe PubMed Central

5 August 2017

Martina Sester

8

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

11 September 2013

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

8

1 reference

Europe PubMed Central

5 August 2017

9

1 reference

Europe PubMed Central

5 August 2017

e69892

1 reference

Europe PubMed Central

5 August 2017

copyright license

Creative Commons Attribution 4.0 International

11 September 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Longitudinal changes in CD4(+) T-cell memory responses induced by BCG vaccination of newborns

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Immune responses in the skin in old age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Initiation and regulation of T-cell responses in tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Do prognostic parameters of remission versus relapse after Bacillus Calmette-Guérin (BCG) immunotherapy exist?. analysis of a quarter century of literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with recurrent superficial bladder tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770812

8 July 2018

A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069892

21 January 2018

Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069892

21 January 2018

Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069892

21 January 2018

Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069892

21 January 2018

Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069892

21 January 2018

Analysis of local T lymphocyte subsets upon stimulation with intravesical BCG: a model to study tuberculosis immunity.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069892

21 January 2018

Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069892

21 January 2018

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069892

21 January 2018

Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069892

21 January 2018

Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069892

21 January 2018

Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Words of wisdom. Re: Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T helper 1/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu�rin immunotherapy for carcinoma in situ of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of purified protein derivative skin test and granuloma formation in patients treated with intravesical bacillus Calmette-Guerin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacillus Calmette-Guérin without maintenance therapy for high-risk non-muscle-invasive bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of mainte

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BCG dose reduction by decreasing the instillation frequency: effects on local Th1/Th2 cytokine responses in a mouse model

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/24039703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0069892

1 reference

Europe PubMed Central

5 August 2017

2013PLoSO...869892E

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34988147&oldid=1864032594"